Adjunctive armodafinil for negative symptoms in adults with schizophrenia: A double-blind, placebo-controlled study

This study found no benefit of adjunctive armodafinil versus placebo for negative symptoms in patients with schizophrenia receiving treatment with olanzapine, risperidone, or paliperidone. Armodafinil was generally well tolerated in these patients.